Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients.
The company has 3 R&D and 5 manufacturing facilities.
Financial Results:
Alembic Pharmaceuticals Ltd reported Revenues for Q3FY24 of ₹1,631.00 Crores up from ₹1,509.00 Crore year on year, a rise of 8.08%.
Total Expenses for Q3FY24 of ₹1,448.00 Crores up from ₹1,356.00 Crores year on year, a rise of 6.78%.
Consolidated Net Profit of ₹180.00 Crores up 47.54% from ₹122.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹9.18, up 48.06% from ₹6.20 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.